 | Up a level |
Jeffreys, Laura N, Ardrey, Alison, Hafiz, Taghreed A, Dyer, Lauri-Anne, Warman, Ashley J, Mosallam, Nada, Nixon, Gemma L, Fisher, Nicholas E, Hong, W David, Leung, Suet C et al (show 11 more authors)
(2023)
Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome bd and Chemical Validation of Combination Strategies for Respiratory Inhibitors against Mycobacterium tuberculosis.
ACS INFECTIOUS DISEASES, 9 (2).
pp. 221-238.
Ammerman, Nicole C, Nuermberger, Eric L, Owen, Andrew 
ORCID: 0000-0002-9819-7651, Rannard, Steve P ORCID: 0000-0002-6946-1097, Meyers, Caren Freel and Swindells, Susan
(2022)
Potential Impact of Long-Acting Products on the Control of Tuberculosis: Preclinical Advancements and Translational Tools in Preventive Treatment.
CLINICAL INFECTIOUS DISEASES, 75 (Suppl ).
S510-S516.
Chang, Yong S, Li, Si-Yang, Pertinez, Henry, Betoudji, Fabrice, Lee, Jin, Rannard, Steven P ORCID: 0000-0002-6946-1097, Owen, Andrew ORCID: 0000-0002-9819-7651, Nuermberger, Eric L and Ammerman, Nicole C
(2023)
Using Dynamic Oral Dosing of Rifapentine and Rifabutin to Simulate Exposure Profiles of Long-Acting Formulations in a Mouse Model of Tuberculosis Preventive Therapy.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 67 (7).
e0048123-.